Helvea. News of the failed study contrasts with positive studies presented earlier of rival products Nexavar, made by Bayer AG (BAY), and Erbitux, sold in Europe by Merck KGgA (MRK.XE). 'This is having a negative impact on sentiment, but won't change the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Roche's Avastin Misses Goal in Skin Cancer Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account